Cambridge Epigenetix Limited (CEGX)

CEGX is a University of Cambridge spin-out company pioneering the development of novel and innovative technologies aimed at revolutionising the field of epigenetics research, unlocking the potential epigenetics has as an indicator and influencer of disease, health and wellbeing.

Our easy-to-use products are of the highest-quality and will kick-start your research program.

At Cambridge Epigenetix (CEGX) we believe that methylation matters to human health. So we’re developing best in class tools to make studying DNA methylation as easy as studying DNA sequence.

Our starting point is TrueMethyl™ oxidative bisulfite sequencing (oxBS-Seq), a novel technology that pioneers quantitative, single-base resolution sequencing of the modified bases hydroxymethyl cytosine (5hmC) and methylcytosine (5mC). TrueMethyl enables analysis of the DNA methylome with unprecedented accuracy and opens new avenues for basic research, pharmaceutical discovery and diagnostics.

Recent studies have shown that at some sites in the genome the level of 5hmC can be comparable to the level of 5-mC, emphasizing the importance of identifying these variants accurately.  However, traditional bisulfite sequencing cannot discriminate between 5hmC and 5mC.

Co-invented by Prof. Shankar Balasubramanian, who previously co-invented the Solexa / Illumina sequencing-by-synthesis platform, and Michael Booth, innovative oxBS-Seq technology utilises a selective chemical oxidation that accurately distinguishes between 5-mC and 5-hmC.

TrueMethyl can be used with a variety of common platforms including next generation sequencing systems, methylation arrays, and targeted assays. Employing chemical oxidation gives very high conversion efficiencies and minimises sequence context effects, giving results of unparalleled quality.

Learn more about TrueMethyl

CEGX is funded by leading VC companies GV (Google Ventures), Sequoia and Syncona and our management team comprises industry leaders and epigenetics expertise.

Stay up to date with Cambridge Epigenetix Limited (CEGX)

Login or create a free user account to follow this company and see updates on your dashboard.

Create account